Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-19 Sale | 2024-01-19 7:07 pm | Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO | 15,200 | $3.4706 | $52,753 | 502,485 (Direct) | View |
| 2024-01-19 Sale | 2024-01-19 7:06 pm | Acumen Pharmaceuticals Inc. | ABOS | Meisner Derek M Chief Legal Officer & Corp Sec | 8,933 | $3.4757 | $31,048 | 108,867 (Direct) | View |
| 2024-01-18 Sale | 2024-01-19 7:05 pm | Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO & Chief Business Officer | 4,242 | $3.705 | $15,717 | 211,445 (Direct) | View |
| 2024-01-18 Sale | 2024-01-19 7:05 pm | Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer | 3,124 | $3.7144 | $11,604 | 117,576 (Direct) | View |
| 2024-01-18 Sale | 2024-01-19 7:04 pm | Acumen Pharmaceuticals Inc. | ABOS | Barton Russell Chief Operating Officer | 2,833 | $3.7258 | $10,555 | 96,867 (Direct) | View |
| 2023-08-17 Sale | 2023-08-18 6:31 pm | Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director | 41,949 | $6.492 | $272,334 | 0 (Direct) | View |
| 2023-07-21 Purchase | 2023-07-25 4:30 pm | Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 5,161,290 | $7.75 | $39,999,998 | 14,932,063 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-05 Option Award | 2024-11-06 5:27 pm | N/A 2034-11-05 | Acumen Pharmaceuticals Inc. | ABOS | Schacterle Amy Chief Regulatory Officer | 340,000 | $0 | 340,000 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-10 5:26 pm | N/A 2034-06-09 | Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 25,000 | $0 | 25,000 (Indirect) | View |
| 2024-06-10 Option Award | 2024-06-10 4:54 pm | N/A 2034-06-09 | Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-10 4:51 pm | N/A 2034-06-09 | Acumen Pharmaceuticals Inc. | ABOS | Stoppel Laura Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-10 4:49 pm | N/A 2034-06-09 | Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-10 4:46 pm | N/A 2034-06-09 | Acumen Pharmaceuticals Inc. | ABOS | Porter Derrell Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-10 4:41 pm | N/A 2034-06-09 | Acumen Pharmaceuticals Inc. | ABOS | Fountain Nathan B Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-10 4:40 pm | N/A 2034-06-09 | Acumen Pharmaceuticals Inc. | ABOS | Drapkin Kimberlee C Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-01 5:02 pm | N/A 2034-02-01 | Acumen Pharmaceuticals Inc. | ABOS | Doherty James J. President and CDO | 601,000 | $0 | 601,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:23 pm | N/A 2034-01-01 | Acumen Pharmaceuticals Inc. | ABOS | Barton Russell Chief Operating Officer | 183,000 | $0 | 209,700 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:22 pm | N/A 2034-01-01 | Acumen Pharmaceuticals Inc. | ABOS | Meisner Derek M Chief Legal Officer & Corp Sec | 228,000 | $0 | 254,800 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:21 pm | N/A 2034-01-01 | Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer | 235,000 | $0 | 261,700 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:20 pm | N/A 2034-01-01 | Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO & Chief Business Officer | 265,000 | $0 | 374,687 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:18 pm | N/A 2034-01-01 | Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO | 1,003,000 | $0 | 1,119,685 (Direct) | View |
| 2023-08-17 Exercise | 2023-08-18 6:31 pm | N/A N/A | Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director | 2,800 | $1.19 | 0 (Direct) | View |
| 2023-08-17 Exercise | 2023-08-18 6:31 pm | N/A N/A | Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director | 39,149 | $0.72 | 0 (Direct) | View |
| 2023-08-17 Exercise | 2023-08-18 6:31 pm | N/A 2029-03-01 | Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director | 41,949 | $0 | 0 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-13 4:21 pm | N/A 2033-06-05 | Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 25,000 | $0 | 25,000 (Indirect) | View |
| 2023-06-06 Option Award | 2023-06-07 5:45 pm | N/A 2033-06-05 | Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 5:44 pm | N/A 2033-06-05 | Acumen Pharmaceuticals Inc. | ABOS | Stoppel Laura Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 5:43 pm | N/A 2033-06-05 | Acumen Pharmaceuticals Inc. | ABOS | Porter Derrell Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 5:43 pm | N/A 2033-06-05 | Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 5:42 pm | N/A 2033-06-05 | Acumen Pharmaceuticals Inc. | ABOS | Fountain Nathan B Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 5:40 pm | N/A 2033-06-05 | Acumen Pharmaceuticals Inc. | ABOS | Drapkin Kimberlee C Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-18 4:27 pm | N/A 2033-01-16 | Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO and Chief Business Officer | 184,300 | $0 | 260,487 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-18 4:23 pm | N/A 2033-01-16 | Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer | 146,900 | $0 | 146,900 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-18 4:22 pm | N/A 2033-01-16 | Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO | 586,500 | $0 | 589,185 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-18 4:21 pm | N/A 2033-01-16 | Acumen Pharmaceuticals Inc. | ABOS | Meisner Derek M Chief Legal Office & Corp Sec | 147,600 | $0 | 147,600 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-18 4:19 pm | N/A 2033-01-16 | Acumen Pharmaceuticals Inc. | ABOS | Barton Russell Chief Operating Officer | 146,900 | $0 | 146,900 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-04 7:41 pm | N/A 2033-01-04 | Acumen Pharmaceuticals Inc. | ABOS | Porter Derrell Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-12-29 Exercise | 2023-01-03 5:23 pm | N/A N/A | Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO and Chief Business Officer | 50,000 | $1.19 | 477,556 (Direct) | View |
| 2022-12-29 Exercise | 2023-01-03 5:23 pm | N/A 2031-01-03 | Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO and Chief Business Officer | 50,000 | $0 | 477,556 (Direct) | View |
| 2022-09-06 Option Award | 2022-09-07 4:31 pm | N/A 2032-09-05 | Acumen Pharmaceuticals Inc. | ABOS | Meisner Derek M Chief Legal Office & Corp Sec | 225,000 | $0 | 225,000 (Direct) | View |